Clinical performance of class II MOD fiber reinforced resin composite restorations: an 18-month randomized controlled clinical trial

Abstract Background In recent years, there have been suggestions for new restorative strategies that aim to effectively utilize modern adhesive technologies and protect the remaining intact tooth structure. This study was conducted to evaluate the clinical performance of fiber reinforced resin compo...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamed Hamdy Mohamed, Eman Ali Abouauf, Rania Sayed Mosallam
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Oral Health
Subjects:
Online Access:https://doi.org/10.1186/s12903-025-05521-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571257161252864
author Mohamed Hamdy Mohamed
Eman Ali Abouauf
Rania Sayed Mosallam
author_facet Mohamed Hamdy Mohamed
Eman Ali Abouauf
Rania Sayed Mosallam
author_sort Mohamed Hamdy Mohamed
collection DOAJ
description Abstract Background In recent years, there have been suggestions for new restorative strategies that aim to effectively utilize modern adhesive technologies and protect the remaining intact tooth structure. This study was conducted to evaluate the clinical performance of fiber reinforced resin composites in restoring Class II MOD cavities over 18 months. Methods Forty-five participants with class II MOD cavities were randomly enrolled. The participants were allocated to three groups (n = 15): Group (1) short glass fiber reinforced resin composite (EverX Posterior), Group (2) polyethylene fiber (Ribbond-Ultra) reinforced resin composite and Group (3) only conventional resin composite (Filtek Z250). The modified USPHS criteria were used to evaluate the restorations at baseline; and at three, six, 12 and 18 months. The categorical data were reported as frequencies and percentages. Intergroup comparisons were analyzed using Chi-Square test after Bonferroni correction (P ≤ 0.016). Comparisons within each group were analyzed using Cochran’s Q test after Bonferroni correction (P ≤ 0.005). Results Intergroup comparisons revealed no statistically significant differences in any of the evaluated criteria except for color match. Compared with the other groups, the short glass fiber-reinforced restoration group presented significantly fewer color matches at different follow-up periods. Conclusions Class II direct fiber-reinforced resin composite restorations can offer acceptable performance similar to the nanohybrid resin composite through 18-month of clinical service. Clinical significance Fiber reinforcement of resin composites could be a reliable technique for restoring posterior cavities considering factors such as application complexity, cost and aesthetic considerations. Trial registration The trial was registered retrospectively on (19/05/2022) at https://clinicaltrials.gov with the ID (NCT05380973).
format Article
id doaj-art-a8743480971e48d795b09ceb09a1f185
institution Kabale University
issn 1472-6831
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Oral Health
spelling doaj-art-a8743480971e48d795b09ceb09a1f1852025-02-02T12:45:26ZengBMCBMC Oral Health1472-68312025-01-0125111210.1186/s12903-025-05521-5Clinical performance of class II MOD fiber reinforced resin composite restorations: an 18-month randomized controlled clinical trialMohamed Hamdy Mohamed0Eman Ali Abouauf1Rania Sayed Mosallam2Conservative Dentistry Department, Faculty of Dentistry, Cairo UniversityConservative Dentistry Department, Faculty of Dentistry, Cairo UniversityConservative Dentistry Department, Faculty of Dentistry, Cairo UniversityAbstract Background In recent years, there have been suggestions for new restorative strategies that aim to effectively utilize modern adhesive technologies and protect the remaining intact tooth structure. This study was conducted to evaluate the clinical performance of fiber reinforced resin composites in restoring Class II MOD cavities over 18 months. Methods Forty-five participants with class II MOD cavities were randomly enrolled. The participants were allocated to three groups (n = 15): Group (1) short glass fiber reinforced resin composite (EverX Posterior), Group (2) polyethylene fiber (Ribbond-Ultra) reinforced resin composite and Group (3) only conventional resin composite (Filtek Z250). The modified USPHS criteria were used to evaluate the restorations at baseline; and at three, six, 12 and 18 months. The categorical data were reported as frequencies and percentages. Intergroup comparisons were analyzed using Chi-Square test after Bonferroni correction (P ≤ 0.016). Comparisons within each group were analyzed using Cochran’s Q test after Bonferroni correction (P ≤ 0.005). Results Intergroup comparisons revealed no statistically significant differences in any of the evaluated criteria except for color match. Compared with the other groups, the short glass fiber-reinforced restoration group presented significantly fewer color matches at different follow-up periods. Conclusions Class II direct fiber-reinforced resin composite restorations can offer acceptable performance similar to the nanohybrid resin composite through 18-month of clinical service. Clinical significance Fiber reinforcement of resin composites could be a reliable technique for restoring posterior cavities considering factors such as application complexity, cost and aesthetic considerations. Trial registration The trial was registered retrospectively on (19/05/2022) at https://clinicaltrials.gov with the ID (NCT05380973).https://doi.org/10.1186/s12903-025-05521-5Short fiberEver-X posteriorRibbondPolyethylene fiberClinical performance
spellingShingle Mohamed Hamdy Mohamed
Eman Ali Abouauf
Rania Sayed Mosallam
Clinical performance of class II MOD fiber reinforced resin composite restorations: an 18-month randomized controlled clinical trial
BMC Oral Health
Short fiber
Ever-X posterior
Ribbond
Polyethylene fiber
Clinical performance
title Clinical performance of class II MOD fiber reinforced resin composite restorations: an 18-month randomized controlled clinical trial
title_full Clinical performance of class II MOD fiber reinforced resin composite restorations: an 18-month randomized controlled clinical trial
title_fullStr Clinical performance of class II MOD fiber reinforced resin composite restorations: an 18-month randomized controlled clinical trial
title_full_unstemmed Clinical performance of class II MOD fiber reinforced resin composite restorations: an 18-month randomized controlled clinical trial
title_short Clinical performance of class II MOD fiber reinforced resin composite restorations: an 18-month randomized controlled clinical trial
title_sort clinical performance of class ii mod fiber reinforced resin composite restorations an 18 month randomized controlled clinical trial
topic Short fiber
Ever-X posterior
Ribbond
Polyethylene fiber
Clinical performance
url https://doi.org/10.1186/s12903-025-05521-5
work_keys_str_mv AT mohamedhamdymohamed clinicalperformanceofclassiimodfiberreinforcedresincompositerestorationsan18monthrandomizedcontrolledclinicaltrial
AT emanaliabouauf clinicalperformanceofclassiimodfiberreinforcedresincompositerestorationsan18monthrandomizedcontrolledclinicaltrial
AT raniasayedmosallam clinicalperformanceofclassiimodfiberreinforcedresincompositerestorationsan18monthrandomizedcontrolledclinicaltrial